Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypes.
Tsao T, Buck AM, Grimbert L, LaFranchi BH, Altamirano Poblano B, Fehrman EA, Dalhuisen T, Hsue PY, Kelly JD, Martin JN, Deeks SG, Hunt PW, Peluso MJ, Aguilar OA, Henrich TJ. Tsao T, et al. Among authors: buck am. J Clin Invest. 2024 Dec 17:e188182. doi: 10.1172/JCI188182. Online ahead of print. J Clin Invest. 2024. PMID: 39688913 Free article. No abstract available.
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms.
Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Hoh R, Williams MC, Kerbleski M, Deveau TM, Munter SE, Lombardo J, Wrin T, Petropoulos CJ, Durstenfeld MS, Hsue PY, Kelly JD, Greenhouse B, Martin JN, Deeks SG, Peluso MJ, Henrich TJ. Buck AM, et al. medRxiv [Preprint]. 2023 Mar 31:2023.03.30.23287923. doi: 10.1101/2023.03.30.23287923. medRxiv. 2023. Update in: J Med Virol. 2023 Nov;95(11):e29216. doi: 10.1002/jmv.29216 PMID: 37034660 Free PMC article. Updated. Preprint.
Gaining momentum: stem cell therapies for HIV cure.
Buck AM, LaFranchi BH, Henrich TJ. Buck AM, et al. Curr Opin HIV AIDS. 2024 Jul 1;19(4):194-200. doi: 10.1097/COH.0000000000000859. Epub 2024 Apr 26. Curr Opin HIV AIDS. 2024. PMID: 38686850 Free PMC article. Review.
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID.
Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, Tai V, Torres L, Iyer NS, Deswal M, Ngo LH, Buitrago M, Rodriguez A, Chen JY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Deitchman AN, Hellmuth J, Spinelli MA, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Deeks SG, Hunt PW, Henrich TJ. Peluso MJ, et al. medRxiv [Preprint]. 2022 Jul 22:2022.06.21.22276660. doi: 10.1101/2022.06.21.22276660. medRxiv. 2022. Update in: J Clin Invest. 2023 Feb 1;133(3):e163669. doi: 10.1172/JCI163669 PMID: 35898346 Free PMC article. Updated. Preprint.
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19.
Peluso MJ, Ryder D, Flavell R, Wang Y, Levi J, LaFranchi BH, Deveau TM, Buck AM, Munter SE, Asare KA, Aslam M, Koch W, Szabo G, Hoh R, Deswal M, Rodriguez A, Buitrago M, Tai V, Shrestha U, Lu S, Goldberg SA, Dalhuisen T, Durstenfeld MS, Hsue PY, Kelly JD, Kumar N, Martin JN, Gambir A, Somsouk M, Seo Y, Deeks SG, Laszik ZG, VanBrocklin HF, Henrich TJ. Peluso MJ, et al. Among authors: buck am. medRxiv [Preprint]. 2023 Jul 31:2023.07.27.23293177. doi: 10.1101/2023.07.27.23293177. medRxiv. 2023. PMID: 37577714 Free PMC article. Preprint.
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV.
Henrich TJ, Bosch RJ, Godfrey C, Mar H, Nair A, Keefer M, Fichtenbaum C, Moisi D, Clagett B, Buck AM, Deitchman AN, Aweeka F, Li JZ, Kuritzkes DR, Lederman MM, Hsue PY, Deeks SG; ACTG A5337 Team. Henrich TJ, et al. Among authors: buck am. Cell Rep Med. 2024 Oct 15;5(10):101745. doi: 10.1016/j.xcrm.2024.101745. Epub 2024 Sep 24. Cell Rep Med. 2024. PMID: 39321793 Free PMC article.
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
Peluso MJ, Ryder D, Flavell RR, Wang Y, Levi J, LaFranchi BH, Deveau TM, Buck AM, Munter SE, Asare KA, Aslam M, Koch W, Szabo G, Hoh R, Deswal M, Rodriguez AE, Buitrago M, Tai V, Shrestha U, Lu S, Goldberg SA, Dalhuisen T, Vasquez JJ, Durstenfeld MS, Hsue PY, Kelly JD, Kumar N, Martin JN, Gambhir A, Somsouk M, Seo Y, Deeks SG, Laszik ZG, VanBrocklin HF, Henrich TJ. Peluso MJ, et al. Among authors: buck am. Sci Transl Med. 2024 Jul 3;16(754):eadk3295. doi: 10.1126/scitranslmed.adk3295. Epub 2024 Jul 3. Sci Transl Med. 2024. PMID: 38959327 Free PMC article.
The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Bodansky A, Kung A, Hoh R, Williams MC, Kerbleski M, Maison DP, Deveau TM, Munter SE, Lombardo J, Wrin T, Petropoulos CJ, Durstenfeld MS, Hsue PY, Kelly JD, Greenhouse B, Martin JN, Deeks SG, Peluso MJ, Henrich TJ. Buck AM, et al. J Med Virol. 2023 Nov;95(11):e29216. doi: 10.1002/jmv.29216. J Med Virol. 2023. PMID: 37988251 Free PMC article.
What Is Your Diagnosis?
Buck AM, Sunico SK. Buck AM, et al. J Am Vet Med Assoc. 2020 Jul 15;257(2):147-150. doi: 10.2460/javma.257.2.147. J Am Vet Med Assoc. 2020. PMID: 32597731 Free article. No abstract available.
18 results